Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianchan Capsule plus OxyContin for pain in advanced colorectal cancer
ChiCTR2200063670Phase 4Not yet recruiting
- Sponsor
- Cancer Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in colorectal cancer (CRC) comparing Tianchan Capsule + OxyContin with Placebo + OxyContin (2 arms). Primary endpoint: Pain relief rate. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
Tianchan Capsule
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2200063670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063670.